Hyperendemic human fascioliasis in Andean valleys: An altitudinal transect analysis in children of Cajamarca province, Peru

Acta Tropica

Volumn 120, Issue 1-2, 2011, Pages 119-129

  González, L Carolina ^a   Esteban, José Guillermo ^a   Bargues, M Dolores ^a   Valero, M Adela ^a   Ortiz, Pedro ^b   Náquira, Cesar ^c   Mas Coma, Santiago ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSIDAD NACIONAL DE CAJAMARCA   (Peru)

^c Universidad Nacional Mayor de San Marcos   (Peru)

Author keywords

Altitude; Children; Coinfections; Epidemiology; Fascioliasis; Peru

Indexed keywords

CHILD HEALTH; DISEASE PREVALENCE; DISEASE VECTOR; EPIDEMIOLOGY; RURAL AREA;

ADOLESCENT; ADULT; AGE; ALTITUDE; ARTICLE; CHILD; CHRONICITY; CONTROLLED STUDY; ENDEMIC DISEASE; EPIDEMIOLOGICAL DATA; FASCIOLA HEPATICA; FASCIOLIASIS; FEMALE; HUMAN; MALE; MIXED INFECTION; PARASITE TRANSMISSION; PERU; PRESCHOOL CHILD; PREVALENCE; RURAL AREA; SCHOOL CHILD; SEX DIFFERENCE;

ADOLESCENT; ALTITUDE; ANIMALS; CHILD; CHILD, PRESCHOOL; COINFECTION; ENVIRONMENT; FASCIOLA HEPATICA; FASCIOLIASIS; FECES; FEMALE; HUMANS; MALE; PARASITE EGG COUNT; PERU; PREVALENCE; STATISTICAL DISTRIBUTIONS;

CAJAMARCA; PERU;

FASCIOLA HEPATICA; PROTOZOA; VERMES;

EID: 80052095395     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2011.07.002     Document Type: Article

References (69)

1. Alban Olaya M., Ortiz J.J., Quispe Lazo T. Fasciolasis en Cajamarca. Rev. Gastroenterol. Perú 2002, 22:28-32.
2. Apt W., Aguilera X., Vega F., Alcaino H., Zulantay I., Apt P., Gonzalez V., Retamal C., Rodriguez J., Sandoval J. Prevalencia de fascoliasis en humanos, caballos, cerdos y conejos silvestres en tres provincias de Chile. Bol. Oficina Sanit. Panam. 1993, 115:405-414.
3. Ash L.R., Orihel T.C., Savioli L. Bench Aids for the Diagnosis of Intestinal Parasites 1994, World Health Organization, Geneva.
4. Ashrafi K., Valero M.A., Massoud J., Sobhani A.R., Solaymani-Mohammadi S., Conde P., Khoubbane M., Bargues M.D., Mas-Coma S. Plant-borne human contamination by fascioliasis. Am. J. Trop. Med. Hyg. 2006, 75:295-302.
5. Bargues M.D., Mas-Coma S. Reviewing lymnaeid vectors of fascioliasis by ribosomal DNA sequence analyses. J. Helminthol. 2005, 79:257-267.
6. Bargues M.D., Oviedo J.A., Funatsu I.R., Rodriguez A., Mas-Coma S. Survival of lymnaeid snails from the Bolivian Northern Altiplano after the parasitation by different Bolivian isolates of Fasciola hepatica (Linnaeus, 1758) (Trematoda: Fasciolidae). Unitas Malacologica 1995, 443-445. Instituto de Investigaciones Marinas, CSIC, Vigo. A. Guerra, E. Rolán, F. Rocha (Eds.).
7. Bargues M.D., Artigas P., Mera y Sierra R.L., Pointier J.P., Mas-Coma S. Characterisation of Lymnaea cubensis, L. viatrix and L. neotropica n. sp., the main vectors of Fasciola hepatica in Latin America, by analysis of their ribosomal and mitochondrial DNA. Ann. Trop. Med. Parasitol. 2007, 101:621-641.
8. Blancas G., Terashima A., Maguiña C., Lujan L., Alvarez H., Casanova R.T. Fasciolosis humana y compromiso gastrointestinal: estudio de 277 pacientes en el Hospital Nacional Cayetano Heredia, 1970-2002. Rev. Gastroenterol. Perú 2004, 24:143-157.
9. Chavez, C.E., 1961. La lucha contra la distomatosis. Bol. Infectol. Asoc. Med. Vet. Perú 8, 3-9, and 9, 3-7.
10. Chen M.G., Mott K.E. Progress in assessment of morbidity due to Fasciola hepatica infection: a review of recent literature. Trop. Dis. Bull. 1990, 87:R1-R38.
11. Claxton J.R., Sutherst J., Ortiz P., Clarkson M.J. The effect of cyclic temperatures on the growth of Fasciola hepatica and Lymnaea viatrix. Vet. J. 1999, 157:166-171.
12. Claxton J.R., Zambrano H., Ortiz P., Amoros C., Delgado E., Escurra E., Clarkson M.J. The epidemiology of fasciolosis in the inter-Andean valley of Cajamarca, Peru. Parasitol. Int. 1997, 46:281-288.
13. Claxton J.R., Zambrano H., Ortiz P., Delgado E., Escurra E., Clarkson M.J. Strategic control of fasciolosis in the inter-Andean valley of Cajamarca, Peru. Vet. Rec. 1998, 143:42-45.
14. Cosme-Contreras J., Burga-Hernandez A., Geldres-Moreno L., Bazan-Vasquez C. Estudio clínico y epidemiológico de la distomatosis hepática en escolares de la zona rural de Cajamarca. Rev. Peru Pediatría 1971, 29:165-171.
15. Demirci M., Korkmaz M., Kaya S., Kuman A. Fascioliasis in eosinophilic patients in the Isparta region of Turkey. Infection 2003, 31:15-18.
16. Dittmar K. Arthropod and helminth parasites of the wild guinea pig, Cavia aperea, from the Andes and the Cordillera in Peru, South America. J. Parasitol. 2002, 88:409-411.
17. Espinoza J.R., Maco V., Marcos L., Saez S., Neyra V., Terashima A., Samalvides F., Gotuzzo E., Chavarry E., Huaman C., Bargues M.D., Valero M.A., Mas-Coma S. Evaluation of Fas2-ELISA for the serological detection of Fasciola hepatica infection in humans. Am. J. Trop. Med. Hyg. 2007, 76:977-982.
18. Esteban J.G., Flores A., Aguirre C., Strauss W., Angles R., Mas-Coma S. Presence of very high prevalence and intensity of infection with Fasciola hepatica among Aymara children from the Northern Bolivian Altiplano. Acta Trop. 1997, 66:1-14.
19. Esteban J.G., Flores A., Angles R., Strauss W., Aguirre C., Mas-Coma S. A population-based coprological study of human fascioliasis in a hyperendemic area of the Bolivian Altiplano. Trop. Med. Int. Health 1997, 2:695-699.
20. Esteban J.G., Aguirre C., Flores A., Strauss W., Angles R., Mas-Coma S. High Cryptosporidium prevalences in healthy Aymara children from the Northern Bolivian Altiplano. Am. J. Trop. Med. Hyg. 1998, 58:50-55.
21. Esteban J.G., Aguirre C., Angles R., Ash L.R., Mas-Coma S. Balantidiasis in Aymara children from the Northern Bolivian Altiplano. Am. J. Trop. Med. Hyg. 1998, 59:922-927.
22. Esteban J.G., Flores A., Angles R., Mas-Coma S. High endemicity of human fascioliasis between Lake Titicaca and La Paz valley, Bolivia. Trans. R. Soc. Trop. Med. Hyg. 1999, 93:151-156.
23. Esteban J.G., Gonzalez C., Bargues M.D., Angles R., Sanchez C., Naquira C., Mas-Coma S. High fascioliasis infection in children linked to a man-made irrigation zone in Peru. Trop. Med. Int. Health 2002, 7:339-348.
24. Esteban J.G., Gonzalez C., Curtale F., Muñoz-Antoli C., Valero M.A., Bargues M.D., El Sayed M., El Wakeel A., Abdel-Wahab Y., Montresor A., Engels D., Savioli L., Mas-Coma S. Hyperendemic fascioliasis associated with schistosomiasis in villages in the Nile Delta of Egypt. Am. J. Trop. Med. Hyg. 2003, 69:429-437.
25. Favennec L., Jave Ortiz J., Gargala G., Lopez Chegne N., Ayoub A., Rossignol J.F. Double blind, randomized, placebo-controlled study of nitazoxanide in the treatment of fascioliasis in adults and children from northern Peru. Alim. Pharmacol. Ther. 2003, 17:265-270.
26. Flores A., Esteban J.G., Angles R., Mas-Coma S. Soil-transmitted helminth infections at very high altitude in Bolivia. Trans. R. Soc. Trop. Med. Hyg. 2000, 95:272-277.
27. Fuentes M.V., Valero M.A., Bargues M.D., Esteban J.G., Angles R., Mas-Coma S. Analysis of climatic data and forecast indices for human fascioliasis at very high altitude. Ann. Trop. Med. Parasitol. 1999, 93:835-850.
28. Fuentes M.V., Malone J.B., Mas-Coma S. Validation of a mapping and predicting model for human fasciolosis transmission in Andean very high altitude endemic areas using remote sensing data. Acta Trop. 2001, 79:87-95.
29. Gamarra R.G. Fasciola infection in guinea-pigs in the Peruvian highlands. Trop. Anim. Health Prod. 1996, 28:143-144.
30. Girones N., Valero M.A., Garcia-Bodelon M.A., Chico-Calero M.I., Punzon C., Fresno M., Mas-Coma S. Immune suppression in advanced chronic fascioliasis: an experimental study in a rat model. J. Infect. Dis. 2007, 195:1504-1512.
31. Henriksen S.A., Pohlenz J.F.L. Staining of cryptosporidia by a modified Ziehl-Neelsen technique. Acta Vet. Scand. 1981, 22:594-596.
32. Hien T.T., Truong N.T., Minh N.H., Dat H.D., Dung N.T., Hue N.T., Dubng T.K., Tuan P.Q., Campbell J.I., Farrar J.J., Day J.N. A randomized controlled pilot study of asrtesunate versus triclabendazole for human fascioliasis in central Vietnam. Am. J. Trop. Med. Hyg. 2008, 78:388-392.
33. Hillyer G.V., Soler de Galanes M., Rodriguez-Perez J., Bjorland J., Silva de Lagrava M., Guzman S.R., Bryan R.T. Use of the Falcon™ assay screening test-enzyme-linked immunosorbent assay (FAST-ELISA) and the enzyme-linked immunoelectrotransfer blot (EITB) to determine the prevalence of human fascioliasis in the Bolivian Altiplano. Am. J. Trop. Med. Hyg. 1992, 46:603-609.
34. Hillyer G.V., Soler de Galanes M., Delgado Azañero E. Immunodiagnosis of human fasciolosis in children from Cajamarca, Peru. Parasitol. Día 2001, 25:82-84.
35. Hotez P.J., Bottazzi M.E., Franco-Paredes C., Ault S.K., Roses Periago M. The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination. PLoS Negl. Trop. Dis. 2008, 2:e300.
36. Hotez P.J., Molyneux D.H., Fenwick A., Kumaresan J., Ehrlich Sachs S., et al. Control of neglected tropical diseases. New Engl. J. Med. 2007, 357:1018-1027.
37. Jave J., Alban M., Sagastegui C., Soriano S. Tratamiento de la fasciolasis hepática humana con triclabendazol. Rev. Gastroenterol. Perú 1999, 19:216-220.
38. Knight W.B., Hiatt R.A., Cline B.L., Ritchie L.S. A modification of the formol-ether concentration technique for increased sensitivity in detecting Schistosoma mansoni. Am. J. Trop. Med. Hyg. 1976, 55:818-823.
39. Knobloch J. Human fascioliasis in Cajamarca/Peru. II. Humoral antibody response and antigenaemia. Trop. Med. Parasitol. 1985, 36:91-93.
40. Knobloch J., Delgado E., Alvarez A.G., Reymann U., Bialek R. Human fascioliasis in Cajamarca/Peru. I. Diagnostic methods and treatment with praziquantel. Trop. Med. Parasitol. 1985, 36:88-90.
41. Lumbreras H. Investigación epidemiológica sobre Fasciola hepatica en Cajamarca. I Congreso Nacional Microbiológico y Parasitológico 1964, 54.
42. Marcos L., Maco V., Terashima A., Samalvides F., Espinoza J.R., Gotuzzo E. Hiperendemicidad de fasciolosis humana en el Valle del Mantaro: factores de riesgo de la infección por Fasciola hepatica. Rev. Gastroenterol. Peru 2004, 24:158-164.
43. Mas-Coma S. Epidemiology of fascioliasis in human endemic areas. J. Helminthol. 2005, 79:207-216.
44. Mas-Coma S., Angles R., Esteban J.G., Bargues M.D., Buchon P., Franken M., Strauss W. The Northern Bolivian Altiplano: a region highly endemic for human fascioliasis. Trop. Med. Int. Health 1999, 4:454-467.
45. Mas-Coma S., Funatsu I.R., Bargues M.D. Fasciola hepatica and lymnaeid snails occurring at very high altitude in South America. Parasitology 2001, 123:S115-S127.
46. Mas-Coma S., Valero M.A., Bargues M.D. Effects of climate change on animal and zoonotic helminthiases. Rev. Sci. Tech. OIE 2008, 27:443-457.
47. Mas-Coma S., Valero M.A., Bargues M.D. Fasciola, lymnaeids and human fascioliasis, with a global overview on disease transmission, epidemiology, evolutionary genetics, molecular epidemiology and control. Adv. Parasitol. 2009, 69:41-146.
48. Mas-Coma S., Valero M.A., Bargues M.D. Climate change effects on trematodiases, with emphasis on zoonotic fascioliasis and schistosomiasis. Vet. Parasitol. 2009, 163:264-280.
49. Moghaddam A.S., Massoud J., Mahmoodi M., Mahvi A.H., Periago M.V., Artigas P., Fuentes M.V., Bargues M.D., Mas-Coma S. Human and animal fascioliasis in Mazandaran province, northern Iran. Parasitol. Res. 2004, 94:61-69.
50. O'Neill S.M., Brady M.T., Callanan J.J., Mulcahy G., Joyce P., Mills K.H., Dalton J.P. Fasciola hepatica infection downregulates Th1 responses in mice. Parasite Immunol. 2000, 22:147-155.
51. O'Neill S.M., Kingston H.G., Mills H.K., Dalton J.P. Fasciola hepatica cathepsin L cysteine proteinase suppresses Bordetella pertussis-specific interferon-gamma production in vivo. Parasite Immunol. 2001, 23:541-547.
52. Ollerenshaw C.B., Smith L.P. Meteorological factors and forecast of helminthic diseases. Adv. Parasitol. 1969, 7:232-283.
53. Ortiz P., Cabrera M., Jave J., Claxton J., Williams D. Human fascioliasis: prevalence and treatment in a rural area of Peru. Inf. Dis. Rev. 2000, 2:42-46.
54. Picoaga J., Lopera J., Montes J. Fasciolasis en Arequipa. Bol. Peru Parasitol. 1980, 2:1-11.
55. Rivera-Jacinto M., Rodriguez-Ulloa C., Rojas-Huaman Y., Valdivia-Melendez Y., Saucedo-Duran T. Conocimientos, actitudes y prácticas sobre fascioliasis en madres de una zona rural andina del Norte peruano. Rev. Peru Med. Exp. Salud Públ. 2010, 27:59-62.
56. Rokni M.B. The present status of human helminthic diseases in Iran. Ann. Trop. Med. Parasitol. 2008, 102:283-295.
57. Storck M.G., Venables G.S., Jennings S.M.F., Beesley J.R., Bendezu P., Capron A. An investigation of endemic fascioliasis in Peruvian village children. J. Trop. Med. Hyg. 1973, 76:231-235.
58. Torgerson P., Claxton J. Epidemiology and control. Fasciolosis 1999, 113-149. CAB International Publishing, Wallingford, Oxon, UK. J.P. Dalton (Ed.).
59. Valero M.A., Mas-Coma S. Comparative infectivity of Fasciola hepatica metacercariae from isolates of the main and secondary reservoir animal host species in the Bolivian Altiplano high human endemic region. Folia Parasitol. 2000, 47:17-22.
60. Valero M.A., Darce N.A., Panova M., Mas-Coma S. Relationships between host species and morphometric patterns in Fasciola hepatica adults and eggs from the Northern Bolivian Altiplano hyperendemic region. Vet. Parasitol. 2001, 102:85-100.
61. Valero M.A., Santana M., Morales M., Hernandez J.L., Mas-Coma S. Risk of gallstone disease in advanced chronic phase of fascioliasis: an experimental study in a rat model. J. Inf. Dis. 2003, 188:787-793.
62. Valero M.A., Navarro M., Garcia-Bodelon M.A., Marcilla A., Morales M., Garcia J.E., Hernandez J.L., Mas-Coma S. High risk of bacterobilia in advanced experimental chronic fasciolosis. Acta Trop. 2006, 100:17-23.
63. Valero M.A., Girones N., Garcia-Bodelon M.A., Periago M.V., Chico-Calero I., Khoubbane M., Fresno M., Mas-Coma S. Anaemia in advanced chronic fasciolosis. Acta Trop. 2008, 108:35-43.
64. Valero M.A., Perez-Crespo I., Periago M.V., Khoubbane M., Mas-Coma S. Fluke egg characteristics for the diagnosis of human and animal fascioliasis by Fasciola hepatica and F. gigantica. Acta Trop. 2009, 111:150-159.
65. Vaillant, V., De Valk, H., Baron, E., 2003. Morbidité et mortalité dues aux maladies infectieuses d'origine alimentaire en France. Rapport de l'Institut National de Veille Sanitaire, Ministère de la Santé, de la Famille et des Personnes Handicapées, pp. 1-188.
66. World Health Organization, 1990. Summary of a report on Fasciola hepatica infection in northern Portugal from the Instituto Nacional de Saude, Porto, Portugal, in 1986. Annex in: Progress in assessment of morbidity due to Fasciola hepatica infection: a review of recent literature. World Health Organization, Geneva, WHO/Schisto/90.104, pp. 43-44.
67. World Health Organization, 1995. Control of foodborne trematode infections. WHO Technical Report Series, World Health Organization, Geneva, No. 849, pp. 1-157.
68. World Health Organization, 2007. Report of the WHO Informal Meeting on use of triclabendazole in fascioliasis control. World Health Organization, Headquarters Geneva, 17-18 October 2006: WHO/CDS/NTD/PCT/2007.1.
69. World Health Organization, 2008. Fact sheet on fascioliasis. In: Action Against Worms, World Health Organization, Headquarters Geneva (December 2007), Newsletter 10, pp. 1-8.